JP2019516966A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2019516966A5 JP2019516966A5 JP2018554391A JP2018554391A JP2019516966A5 JP 2019516966 A5 JP2019516966 A5 JP 2019516966A5 JP 2018554391 A JP2018554391 A JP 2018554391A JP 2018554391 A JP2018554391 A JP 2018554391A JP 2019516966 A5 JP2019516966 A5 JP 2019516966A5
- Authority
- JP
- Japan
- Prior art keywords
- acetylglucosamine
- apo
- lectin
- level
- reagent
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP16382167.1A EP3232200A1 (en) | 2016-04-12 | 2016-04-12 | Methods and kits for the diagnosis and risk stratification of patients with ischemia |
| EP16382167.1 | 2016-04-12 | ||
| PCT/EP2017/058768 WO2017178521A1 (en) | 2016-04-12 | 2017-04-12 | Methods and kits for the diagnosis and risk stratification of patients with ischemia |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2019516966A JP2019516966A (ja) | 2019-06-20 |
| JP2019516966A5 true JP2019516966A5 (enExample) | 2021-04-08 |
| JP7075894B2 JP7075894B2 (ja) | 2022-05-26 |
Family
ID=56008566
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2018554391A Expired - Fee Related JP7075894B2 (ja) | 2016-04-12 | 2017-04-12 | 虚血を有する患者の診断およびリスク層別化のための方法およびキット |
Country Status (15)
| Country | Link |
|---|---|
| US (1) | US11486884B2 (enExample) |
| EP (2) | EP3232200A1 (enExample) |
| JP (1) | JP7075894B2 (enExample) |
| KR (1) | KR102344344B1 (enExample) |
| CN (1) | CN109154620B (enExample) |
| AU (1) | AU2017251355A1 (enExample) |
| BR (1) | BR112018070971A2 (enExample) |
| CA (1) | CA3020666A1 (enExample) |
| ES (1) | ES2979390T3 (enExample) |
| IL (1) | IL262245B (enExample) |
| MA (1) | MA44658A (enExample) |
| MX (1) | MX2018012580A (enExample) |
| RU (1) | RU2750035C2 (enExample) |
| SG (1) | SG11201808820QA (enExample) |
| WO (1) | WO2017178521A1 (enExample) |
Families Citing this family (22)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20210388108A1 (en) * | 2018-10-23 | 2021-12-16 | Glycardial Diagnostics, S.L. | Antibodies specific for glycosylated apoj and uses thereof |
| CN113395994A (zh) * | 2018-12-05 | 2021-09-14 | 格雷卡迪亚尔诊断有限公司 | 用于预防和/或治疗缺血和治疗缺血/再灌注损伤的方法和组合物 |
| KR102158726B1 (ko) | 2019-04-17 | 2020-09-22 | 한림대학교 산학협력단 | Itpr3 유전자 업스트림의 유전자간 영역을 포함하는 지연성 허혈 진단용 dna 메틸화 마커 조성물 |
| KR102281657B1 (ko) | 2019-12-23 | 2021-07-26 | 한림대학교 산학협력단 | 지연성 허혈 진단을 위한 cdhr5 유전자 과메틸화 마커 |
| KR102281644B1 (ko) | 2019-12-23 | 2021-07-23 | 한림대학교 산학협력단 | 지연성 허혈 진단을 위한 insr 유전자 과메틸화 마커 |
| KR102312534B1 (ko) | 2019-12-31 | 2021-10-13 | 한림대학교 산학협력단 | 뇌척수액 유래 미토콘드리아 마커를 이용한 지연성 허혈 진단 방법 |
| KR102318236B1 (ko) | 2020-02-18 | 2021-10-26 | 한림대학교 산학협력단 | 혈중 코펩틴의 농도를 이용한 지연성 뇌허혈 진단 방법 |
| KR102336507B1 (ko) | 2020-02-21 | 2021-12-06 | 한림대학교 산학협력단 | 국소뇌산소포화도를 이용한 지연성 뇌허혈 진단 방법 |
| KR102369155B1 (ko) | 2020-07-07 | 2022-02-28 | 한림대학교 산학협력단 | 근적외선 분광분석법을 이용한 지연성 뇌허혈 진단 방법 |
| KR102473350B1 (ko) | 2020-09-11 | 2022-12-05 | 한림대학교 산학협력단 | 지연성 뇌허혈 진단을 위한 racgap1 유전자 과메틸화 마커 |
| KR102473349B1 (ko) | 2020-09-11 | 2022-12-05 | 한림대학교 산학협력단 | 지연성 뇌허혈 진단을 위한 kifap3 유전자 과메틸화 마커 |
| KR102496589B1 (ko) | 2020-09-11 | 2023-02-03 | 한림대학교 산학협력단 | 지연성 뇌허혈 진단을 위한 vhl 유전자 과메틸화 마커 |
| KR102473348B1 (ko) | 2020-09-11 | 2022-12-05 | 한림대학교 산학협력단 | 지연성 뇌허혈 진단을 위한 kif3a 유전자 과메틸화 마커 |
| KR102477501B1 (ko) | 2020-09-15 | 2022-12-14 | 한림대학교 산학협력단 | 지연성 뇌허혈 진단을 위한 alb 유전자 저메틸화 마커 |
| KR102477500B1 (ko) | 2020-09-15 | 2022-12-14 | 한림대학교 산학협력단 | 지연성 뇌허혈 진단을 위한 oprm1 유전자 과메틸화 마커 |
| KR102477502B1 (ko) | 2020-09-15 | 2022-12-14 | 한림대학교 산학협력단 | 지연성 뇌허혈 진단을 위한 il5 유전자 저메틸화 마커 |
| KR102466956B1 (ko) | 2020-11-05 | 2022-11-11 | 한림대학교 산학협력단 | 지연성 뇌허혈 진단을 위한 dapk1 바이오마커 |
| KR102398533B1 (ko) | 2020-11-05 | 2022-05-13 | 한림대학교 산학협력단 | 지연성 뇌허혈 진단을 위한 뇌척수액 마이토파지 마커 |
| KR102470789B1 (ko) | 2020-11-05 | 2022-11-25 | 한림대학교 산학협력단 | 지연성 뇌허혈 진단을 위한 pink1 바이오마커 |
| KR102398534B1 (ko) | 2020-11-05 | 2022-05-13 | 한림대학교 산학협력단 | 지연성 뇌허혈 진단을 위한 bnip3l 바이오마커 |
| CN113462744B (zh) * | 2021-05-24 | 2023-06-23 | 中国药科大学 | N-乙酰葡萄糖胺作为标志物在制备诊断缺血性脑中风试剂中的应用 |
| KR102865129B1 (ko) | 2021-08-06 | 2025-09-26 | 에이치앤비지노믹스 주식회사 | 지능형 오믹스 기반 개인별 맞춤형 복잡질환 발병 위험도 정보 제공 방법 및 장치 |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6140045A (en) | 1995-03-10 | 2000-10-31 | Meso Scale Technologies | Multi-array, multi-specific electrochemiluminescence testing |
| CA2301634A1 (en) * | 1997-07-15 | 1999-01-28 | Pradeep Ghosh | Determining alcohol intake using sialic acid/apo j |
| US6197599B1 (en) | 1998-07-30 | 2001-03-06 | Guorong Chin | Method to detect proteins |
| US20090166224A1 (en) * | 2004-05-05 | 2009-07-02 | Ziping Yang | Multi-lectin affinity chromatography and uses thereof |
| US9796761B2 (en) * | 2009-07-14 | 2017-10-24 | National Institute Of Advanced Industrial Science And Technology | Glycan markers as measure of disease state of hepatic diseases |
| ES2364169B1 (es) | 2010-02-09 | 2012-07-10 | CONSEJO SUPERIOR DE INVESTIGACIONES CIENTÍFICAS (CSIC) (Titular al 50%) | Uso de las isoformas de apo j como biomarcadores de lesión tisular. |
| EP2400304A1 (en) | 2010-06-22 | 2011-12-28 | Centro de Investigación Cooperativa En Biomateriales ( CIC biomaGUNE) | Method for the characterization of intermolecular interactions |
| JP2012107932A (ja) | 2010-11-16 | 2012-06-07 | Mitsubishi Chemicals Corp | Ｃｌｕｓｔｅｒｉｎ蛋白質による脳梗塞の検査方法 |
| KR102462056B1 (ko) | 2015-04-30 | 2022-11-02 | 아이덱스 래보러토리즈, 인코포레이티드 | 클루스테린 아이소폼의 특이적 검출 |
| CN107957498A (zh) * | 2016-10-18 | 2018-04-24 | 厦门德馨尚品医疗科技有限公司 | 一种含有载脂蛋白j的试剂盒及其在临床诊断中的应用 |
-
2016
- 2016-04-12 EP EP16382167.1A patent/EP3232200A1/en not_active Withdrawn
-
2017
- 2017-04-12 KR KR1020187032609A patent/KR102344344B1/ko not_active Expired - Fee Related
- 2017-04-12 US US16/092,703 patent/US11486884B2/en active Active
- 2017-04-12 BR BR112018070971A patent/BR112018070971A2/pt not_active Application Discontinuation
- 2017-04-12 CN CN201780029342.8A patent/CN109154620B/zh not_active Expired - Fee Related
- 2017-04-12 AU AU2017251355A patent/AU2017251355A1/en not_active Abandoned
- 2017-04-12 JP JP2018554391A patent/JP7075894B2/ja not_active Expired - Fee Related
- 2017-04-12 SG SG11201808820QA patent/SG11201808820QA/en unknown
- 2017-04-12 MX MX2018012580A patent/MX2018012580A/es unknown
- 2017-04-12 EP EP17717159.2A patent/EP3443353B1/en active Active
- 2017-04-12 CA CA3020666A patent/CA3020666A1/en active Pending
- 2017-04-12 MA MA044658A patent/MA44658A/fr unknown
- 2017-04-12 RU RU2018139780A patent/RU2750035C2/ru active
- 2017-04-12 WO PCT/EP2017/058768 patent/WO2017178521A1/en not_active Ceased
- 2017-04-12 ES ES17717159T patent/ES2979390T3/es active Active
-
2018
- 2018-10-09 IL IL262245A patent/IL262245B/en active IP Right Grant
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2019516966A5 (enExample) | ||
| Bivona et al. | Biomarkers for prognosis and treatment response in COVID-19 patients | |
| Qu et al. | Blood biomarkers for the diagnosis of amnestic mild cognitive impairment and Alzheimer’s disease: A systematic review and meta-analysis | |
| JP2019530875A5 (enExample) | ||
| Nickel et al. | The role of copeptin as a diagnostic and prognostic biomarker for risk stratification in the emergency department | |
| Dähnrich et al. | Development of a standardized ELISA for the determination of autoantibodies against human M-type phospholipase A2 receptor in primary membranous nephropathy | |
| Oran et al. | Ischemia‐Modified Albumin as a Marker of Acute Coronary Syndrome: The Case for Revising the Concept of “N‐Terminal Modification” to “Fatty Acid Occupation” of Albumin | |
| CN105765386B (zh) | 用于检测中和抗体的竞争性配体结合测定法 | |
| Lim et al. | An electrochemical biosensor for detection of the sepsis-related biomarker procalcitonin | |
| RU2018139780A (ru) | Способы и наборы диагностики и стратификации риска пациентов с ишемией | |
| CN102203621A (zh) | 用于初次慢性肾脏疾病的发展的预后生物标志物 | |
| JP2015519564A5 (enExample) | ||
| WO2013153177A1 (en) | Prognosis of adverse events in patients with suspected chronic heart failure | |
| Lau et al. | Qualification and application of an ELISA for the determination of Tamm Horsfall protein (THP) in human urine and its use for screening of kidney stone disease | |
| Furuya et al. | Analytical validation of ONCURIA™ a multiplex bead-based immunoassay for the non-invasive bladder cancer detection | |
| CN104272112B (zh) | 用于帮助诊断中风的基于生物标记的方法和生物芯片 | |
| Neves et al. | Neutrophil gelatinase-associated lipocalin detection using a sensitive electrochemical immunosensing approach | |
| Vashist | Graphene-based immunoassay for human lipocalin-2 | |
| Omland | New features of troponin testing in different clinical settings | |
| WO2003081236B1 (en) | Method and device for predicting cardiovascular events | |
| Mullins et al. | Enzyme-linked immunoassay for plasma-free metanephrines in the biochemical diagnosis of phaeochromocytoma in adults is not ideal. | |
| WO2013023233A1 (en) | Method for diagnosis, prognosis or treatment of acute coronary syndrome (acs) comprising measurement of plasma concentration of macrophage migration inhibitory factor (mif) | |
| JP5686431B2 (ja) | 卵巣癌の検出方法、並びに、キット | |
| Richards | Biomarkers in acute heart failure–cardiac and kidney | |
| Wang et al. | Development of a novel immunoassay for the simple and fast quantitation of neutrophil gelatinase-associated lipocalin using europium (III) chelate microparticles and magnetic beads |